Latest News in the pharma Industry

All

IPF patients treated with Ofev vs placebo twice as likely to have improved or stable lung function

IPF patients treated with Ofev vs placebo twice as likely to have improved or stable lung function

25 May 2017

Separate subgroup analysis demonstrates long-term efficacy of Ofev in slowing disease progression is maintained for up to 96 weeks in IPF patients who require dose adjustments to manage adverse events.

Read more 
Bioverativ to acquire clinical-stage rare disease biotechnology company, True North Therapeutics

Bioverativ to acquire clinical-stage rare disease biotechnology company, True North Therapeutics

25 May 2017

Strengthens pipeline with lead candidate TNT009 in cold agglutinin disease, a rare and chronic autoimmune hemolytic anemia with no approved therapies.

Read more 
FDA approves Kevzara for the treatment of moderately to severely active RA in adults

FDA approves Kevzara for the treatment of moderately to severely active RA in adults

23 May 2017

Kevzara is now available to US patients.

Read more 
New analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated with steroids

New analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated with steroids

23 May 2017

New analyses from the FLAME study suggest dual bronchodilator Ultibro Breezhaler provides similar or better efficacy versus steroid-containing therapies, regardless of blood eosinophil counts.

Read more 
Spiriva Respimat inhalation spray improves breathing for people with asthma regardless of BMI or allergic status

Spiriva Respimat inhalation spray improves breathing for people with asthma regardless of BMI or allergic status

23 May 2017

In all analyses, people experiencing uncontrolled asthma symptoms saw improvements in their breathing by adding Spiriva Respimat to an ICS or combination ICS/LABA.

Read more 
FDA approves Genentech’s Actemra for giant cell arteritis

FDA approves Genentech’s Actemra for giant cell arteritis

22 May 2017

Sixth FDA approval for Actemra since its US launch in 2010,

Read more 
Thermo Fisher Scientific to acquire Patheon

Thermo Fisher Scientific to acquire Patheon

22 May 2017

Patheon provides entry into the attractive, high-growth CDMO market.

Read more 
Boehringer Ingelheim inaugurates biopharmaceutical manufacturing facility in China

Boehringer Ingelheim inaugurates biopharmaceutical manufacturing facility in China

22 May 2017

It is the first and only biopharmaceutical manufacturing site established by a multinational active pharmaceutical company in China.

Read more 
Hikma launches generic version on Edecrin in the US market

Hikma launches generic version on Edecrin in the US market

20 May 2017

Product adds to the company's non-injectables portfolio in the US.

Read more 
EMA validates application for BMS’s Sprycel in children with chronic myelogenous leukemia

EMA validates application for BMS’s Sprycel in children with chronic myelogenous leukemia

20 May 2017

Proposal extends application to the treatment of children and adolescents with chronic phase Philadelphia-chromosome positive chronic myelogenous leukemia and to the powder for oral suspension.

Read more 
Biogen acquires Remedy Pharmaceuticals’ Cirara for large hemispheric stroke

Biogen acquires Remedy Pharmaceuticals’ Cirara for large hemispheric stroke

19 May 2017

Phase III-ready program complements Biogen’s ongoing development efforts in stroke.

Read more 
Irvine Scientific launches new xeno-free medium for hematopoietic progenitor cell culture

Irvine Scientific launches new xeno-free medium for hematopoietic progenitor cell culture

19 May 2017

New medium designed for hematopoietic cell culture for cell-based therapies.

Read more